Bioventix PLC
LSE:BVXP
Bioventix PLC
LSE:BVXP
Price:
4 350 GBX
-0.57%
Market Closed
Updated:
May 21, 2024
Bioventix PLC
Selling, General & Administrative
|
Bioventix PLC
Selling, General & Administrative Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bioventix PLC
LSE:BVXP
|
Selling, General & Administrative
-£2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-11%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Selling, General & Administrative
-$53.7m
|
CAGR 3-Years
-261%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Selling, General & Administrative
-$54.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Selling, General & Administrative
-$62.3m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Selling, General & Administrative
-£144.5m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Selling, General & Administrative
-£7.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
See Also
What is Bioventix PLC's Selling, General & Administrative?
Selling, General & Administrative
-2m
GBP
-2m
GBP
Based on the financial report for Dec 31, 2023, Bioventix PLC's Selling, General & Administrative amounts to -2m GBP.
What is Bioventix PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-11%
-11%
Over the last year, the Selling, General & Administrative growth was 1%. The average annual Selling, General & Administrative growth rates for Bioventix PLC have been -7% over the past three years , -8% over the past five years , and -11% over the past ten years .
You don't have any saved screeners yet
